Abstract

The care of patients with endocrine disorders during the coronavirus disease 2019 (COVID-19) pandemic poses unique challenges. Patients with diabetes are at risk for more severe illness. COVID-19 appears to precipitate severe manifestations of diabetes, including diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), and severe insulin resistance.

This topic will review the care of patients with diabetes during the COVID-19 pandemic. Other important aspects of COVID-19 care are discussed separately.